Mimedx (MDXG) Gross Profit Growth (1y) (2012 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 75.94% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 7.76% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 16.94% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 2,488.21% |
| 10 | Mimedx | 530.69 Mn | 370.92 Mn | 41.62 Mn | -41.91% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -41.91% |
| Dec 31, 2025 | 30.32% |
| Sep 30, 2025 | 38.22% |
| Jun 30, 2025 | 10.47% |
| Mar 31, 2025 | -0.10% |
| Dec 31, 2024 | 4.12% |
| Sep 30, 2024 | 2.71% |
| Jun 30, 2024 | 6.91% |
| Mar 31, 2024 | 21.04% |
| Dec 31, 2023 | 21.64% |
| Sep 30, 2023 | 20.58% |
| Jun 30, 2023 | 22.91% |
| Mar 31, 2023 | 21.04% |
| Dec 31, 2022 | 37.27% |
| Sep 30, 2022 | 4.83% |
| Jun 30, 2022 | -0.62% |
| Mar 31, 2022 | -2.72% |
| Dec 31, 2021 | -24.28% |
| Sep 30, 2021 | -1.98% |
| Jun 30, 2021 | 21.91% |
| Mar 31, 2021 | -2.68% |
| Dec 31, 2020 | -9.36% |
| Sep 30, 2020 | -28.61% |
| Jun 30, 2020 | -21.22% |
| Mar 31, 2020 | -12.56% |
| Dec 31, 2019 | -22.50% |
| Sep 30, 2019 | -4.96% |
| Jun 30, 2019 | -33.04% |
| Mar 31, 2019 | -20.93% |
| Dec 31, 2018 | 4.75% |
| Sep 30, 2018 | 6.57% |
| Jun 30, 2018 | 19.65% |
| Mar 31, 2018 | 23.08% |
| Dec 31, 2017 | 29.02% |
| Sep 30, 2017 | 32.37% |
| Jun 30, 2017 | 44.15% |
| Mar 31, 2017 | 33.78% |
| Dec 31, 2016 | 29.79% |
| Sep 30, 2016 | 28.15% |
| Jun 30, 2016 | 23.05% |
| Mar 31, 2016 | 27.52% |
| Dec 31, 2015 | 30.23% |
| Sep 30, 2015 | 45.96% |
| Jun 30, 2015 | 77.77% |
| Mar 31, 2015 | 114.81% |
| Dec 31, 2014 | 141.71% |
| Sep 30, 2014 | 115.47% |
| Jun 30, 2014 | 101.78% |
| Mar 31, 2014 | 71.82% |
| Dec 31, 2013 | 68.74% |
| Sep 30, 2013 | 114.46% |
| Jun 30, 2013 | 200.24% |
| Mar 31, 2013 | 251.33% |
| Dec 31, 2012 | 413.05% |
| Sep 30, 2012 | 415.89% |
| Jun 30, 2012 | 247.55% |
| Mar 31, 2012 | 724.01% |